QQ客服 官方微博 反馈留言

	Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer
	Liu, Jin; Wang, Chuifang; Liu, Xiangyan; Wang, Yu; Liu, Haibo; Ren, Guohua; Zhu, Liangming; Sun, Zhigang; Chen, Zhitao
刊名	ONCOLOGY LETTERS
	2017
卷号	13期号:6页码:4469-4474
关键词	miR-1469 progression relapse prognosis esophageal squamous cell cancer
DOI	10.3892/ol.2017.5957
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4588670
专题	山东大学
作者单位	1.Shandong Univ, Shandong Prov Hosp, Dept Gastroenterol, Jinan 250021, Shandong, Peoples R China. 2.Liaocheng Tumor Hosp, D
推荐引用方式 GB/T 7714	Liu, Jin,Wang, Chuifang,Liu, Xiangyan,et al. Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer[J]. ONCOLOGY LETTERS,2017,13(6):4469-4474.
APA	Liu, Jin.,Wang, Chuifang.,Liu, Xiangyan.,Wang, Yu.,Liu, Haibo.,...&Chen, Zhitao.(2017).Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer.ONCOLOGY LETTERS,13(6),4469-4474.
MLA	Liu, Jin,et al."Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer".ONCOLOGY LETTERS 13.6(2017):4469-4474.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。